Evidence map›Paper›PMID 42346232›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Regional Variations in Guideline Concordance for Women with Triple-Negative and HER2+ Breast Cancer in Nova Scotia.

Andrea Mayo, Hanna Stewart, Tongtong Li, Cameron Penny, Rachel Hemsworth, Ashley Drohan, Katerina Neumann, Boris Gala-Lopez, Richard T Spence, Gregory Knapp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrea MayoBreast Health Research Unit, Izaak Walton Killam Health Centre, Halifax, NS B3K 6R8, Canada.
Hanna StewartBreast Health Research Unit, Izaak Walton Killam Health Centre, Halifax, NS B3K 6R8, Canada.
Tongtong LiDepartment of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada.ORCID 0009-0007-6613-9485
Cameron PennyDepartment of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada.
Rachel HemsworthBreast Health Research Unit, Izaak Walton Killam Health Centre, Halifax, NS B3K 6R8, Canada.
Ashley DrohanBreast Health Research Unit, Izaak Walton Killam Health Centre, Halifax, NS B3K 6R8, Canada.
Katerina NeumannDepartment of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada.ORCID 0000-0002-0506-0219
Boris Gala-LopezDepartment of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada.
Richard T SpenceDepartment of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada.
Gregory KnappBreast Health Research Unit, Izaak Walton Killam Health Centre, Halifax, NS B3K 6R8, Canada.ORCID 0000-0002-9305-1709

Funding

J & W Murphy Foundation No Grant Number
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Erb-b2 Receptor Tyrosine KinasesGuideline AdherenceNeoadjuvant TherapyTriple Negative Breast NeoplasmsAdolescentAdultAgedAged, 80 and overFemaleHumansMiddle AgedNova ScotiaRetrospective StudiesYoung AdultERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesHER2neoadjuvant therapypathologic complete responsetriple-negative breast cancer

Identifiers

PMID42346232
PMCPMC13298986

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.